338 related articles for article (PubMed ID: 14734523)
21. IL-6 expression is correlated with increased T-cell proliferation and survival in the arterial wall in giant cell arteritis.
Manku S; Wong W; Luo Z; Seidman MA; Alabdurubalnabi Z; Rey K; Enns W; Avina-Zubieta JA; Shojania K; Choy JC
Cardiovasc Pathol; 2018; 33():55-61. PubMed ID: 29414433
[TBL] [Abstract][Full Text] [Related]
22. DNA methylation analysis of the temporal artery microenvironment in giant cell arteritis.
Coit P; De Lott LB; Nan B; Elner VM; Sawalha AH
Ann Rheum Dis; 2016 Jun; 75(6):1196-202. PubMed ID: 26038090
[TBL] [Abstract][Full Text] [Related]
23. [Pathogenesis of primary large vessel arteritis].
Arnaud L; Haroche J; Duhaut P; Piette JC; Amoura Z
Rev Med Interne; 2009 Jul; 30(7):578-84. PubMed ID: 18804314
[TBL] [Abstract][Full Text] [Related]
24. Predictors for treatment success and expression of glucocorticoid receptor in giant cell arteritis and polymyalgia rheumatica.
Braun N; Fritz P; Rieth A; Schroth W; Kimmel M; Biegger D; Zakim D; Alscher MD
J Rheumatol; 2009 Oct; 36(10):2269-76. PubMed ID: 19684157
[TBL] [Abstract][Full Text] [Related]
25. Circulating CD8+ T cells in polymyalgia rheumatica and giant cell arteritis: a review.
Martinez-Taboada VM; Blanco R; Fito C; Pacheco MJ; Delgado-Rodriguez M; Rodriguez-Valverde V
Semin Arthritis Rheum; 2001 Feb; 30(4):257-71. PubMed ID: 11182026
[TBL] [Abstract][Full Text] [Related]
26. Glucocorticoid-mediated repression of cytokine gene transcription in human arteritis-SCID chimeras.
Brack A; Rittner HL; Younge BR; Kaltschmidt C; Weyand CM; Goronzy JJ
J Clin Invest; 1997 Jun; 99(12):2842-50. PubMed ID: 9185506
[TBL] [Abstract][Full Text] [Related]
27. The pathogenic role of T lymphocytes in vasculitis.
Weyand CM; Goronzy JJ
Sarcoidosis Vasc Diffuse Lung Dis; 1996 Oct; 13(3):217-20. PubMed ID: 8946585
[TBL] [Abstract][Full Text] [Related]
28. Expression of the class I interferon-related MxA protein in temporal arteries in polymyalgia rheumatica and temporal arteritis.
Nordborg C; Larsson K; Aman P; Nordborg E
Scand J Rheumatol; 2009; 38(2):144-8. PubMed ID: 19177264
[TBL] [Abstract][Full Text] [Related]
29. Intercellular adhesion molecule 1 gene polymorphisms in polymyalgia rheumatica/giant cell arteritis: association with disease risk and severity.
Salvarani C; Casali B; Boiardi L; Ranzi A; Macchioni P; Nicoli D; Farnetti E; Brini M; Portioli I
J Rheumatol; 2000 May; 27(5):1215-21. PubMed ID: 10813290
[TBL] [Abstract][Full Text] [Related]
30. Vessel wall-embedded dendritic cells induce T-cell autoreactivity and initiate vascular inflammation.
Han JW; Shimada K; Ma-Krupa W; Johnson TL; Nerem RM; Goronzy JJ; Weyand CM
Circ Res; 2008 Mar; 102(5):546-53. PubMed ID: 18202318
[TBL] [Abstract][Full Text] [Related]
31. Recent advances in our understanding of giant cell arteritis pathogenesis.
Samson M; Corbera-Bellalta M; Audia S; Planas-Rigol E; Martin L; Cid MC; Bonnotte B
Autoimmun Rev; 2017 Aug; 16(8):833-844. PubMed ID: 28564617
[TBL] [Abstract][Full Text] [Related]
32. Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica.
González-Gay MA; García-Porrúa C; Vázquez-Caruncho M
J Rheumatol; 1998 Sep; 25(9):1750-5. PubMed ID: 9733456
[TBL] [Abstract][Full Text] [Related]
33. An uneven expression of T cell receptor V genes in the arterial wall and peripheral blood in giant cell arteritis.
Schaufelberger C; Andersson R; Nordborg E; Hansson GK; Nordborg C; Wahlström J
Inflammation; 2008 Dec; 31(6):372-83. PubMed ID: 18975064
[TBL] [Abstract][Full Text] [Related]
34. Clonally expanded CD8 T cells in patients with polymyalgia rheumatica and giant cell arteritis.
Martinez-Taboada VM; Goronzy JJ; Weyand CM
Clin Immunol Immunopathol; 1996 Jun; 79(3):263-70. PubMed ID: 8635285
[TBL] [Abstract][Full Text] [Related]
35. Current understanding and management of giant cell arteritis and polymyalgia rheumatica.
Ghosh P; Borg FA; Dasgupta B
Expert Rev Clin Immunol; 2010 Nov; 6(6):913-28. PubMed ID: 20979556
[TBL] [Abstract][Full Text] [Related]
36. Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica.
González-Gay MA; Amoli MM; Garcia-Porrua C; Ollier WE
Semin Arthritis Rheum; 2003 Aug; 33(1):38-48. PubMed ID: 12920695
[TBL] [Abstract][Full Text] [Related]
37. A longitudinal study of anticardiolipin antibody in polymyalgia rheumatica and giant cell arteritis.
Chakravarty K; Pountain G; Merry P; Byron M; Hazleman B; Scott DG
J Rheumatol; 1995 Sep; 22(9):1694-7. PubMed ID: 8523347
[TBL] [Abstract][Full Text] [Related]
38. [Giant cell arteritis (temporal arteritis). Pathophysiology, immunology].
Wagner AD
Ophthalmologe; 2006 Apr; 103(4):302-7. PubMed ID: 16541271
[TBL] [Abstract][Full Text] [Related]
39. The immunoinhibitory PD-1/PD-L1 pathway in inflammatory blood vessel disease.
Weyand CM; Berry GJ; Goronzy JJ
J Leukoc Biol; 2018 Mar; 103(3):565-575. PubMed ID: 28848042
[TBL] [Abstract][Full Text] [Related]
40. Giant cell arteritis and polymyalgia rheumatica can be differentiated by distinct patterns of HLA class II association.
Dababneh A; Gonzalez-Gay MA; Garcia-Porrua C; Hajeer A; Thomson W; Ollier W
J Rheumatol; 1998 Nov; 25(11):2140-5. PubMed ID: 9818656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
